ChiCTR2400094480 版本V1.0 版本创建时间2024/12/24 08:43:00 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400094480 

最近更新日期:

Date of Last Refreshed on:

2024-12-24 08:42:53 

注册时间:

Date of Registration:

2024-12-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

全身麻醉手术术后患者自控静脉镇痛合理化用药的真实世界研究

Public title:

A real-world study of rational use of patient-controlled intravenous analgesia after general anesthesia surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

全身麻醉手术术后患者自控静脉镇痛合理化用药的真实世界研究

Scientific title:

A real-world study of rational use of patient-controlled intravenous analgesia after general anesthesia surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

汪信 

研究负责人:

张英 

Applicant:

Wang Xin 

Study leader:

Zhang Ying 

申请注册联系人电话:

Applicant telephone:

+86 151 8251 9536

研究负责人电话:

Study leader's
telephone:

+86 135 5172 0908

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

549345240@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhangying021210@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省泸州市龙马潭区春晖路182号

研究负责人通讯地址:

四川省泸州市龙马潭区春晖路182号

Applicant address:

182 Chunhui Road, Longmatan District, Luzhou City, Sichuan Province

Study leader's address:

182 Chunhui Road, Longmatan District, Luzhou City, Sichuan Province

申请注册联系人邮政编码:

Applicant postcode:

646000

研究负责人邮政编码:

Study leader's postcode:

646000

申请人所在单位:

西南医科大学附属中医医院

Applicant's institution:

Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

研究负责人所在单位:

西南医科大学附属中医医院

Affiliation of the Leader:

Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY2024063

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

西南医科大学附属中医医院医学伦理审查委员会

Name of the ethic committee:

Medical Ethics Review Committee of the Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-11-26 00:00:00

伦理委员会联系人:

贾强

Contact Name of the ethic committee:

Jia Qiang

伦理委员会联系地址:

泸州市龙马潭区春晖路182号

Contact Address of the ethic committee:

Luzhou City Longmatan District Chunhui Road No.182

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 830 251 6312

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

西南医科大学附属中医医院

Primary sponsor:

Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

研究实施负责(组长)单位地址:

泸州市龙马潭区春晖路182号

Primary sponsor's address:

Luzhou City Longmatan District Chunhui Road No.182

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

泸州市

Country:

China

Province:

Sichuan Province

City:

Luzhou City

单位(医院):

西南医科大学附属中医医院

具体地址:

四川省泸州市龙马潭区春晖路182号

Institution
hospital:

Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

Address:

182 Chunhui Road, Longmatan District, Luzhou City, Sichuan Province

经费或物资来源:

Source(s) of funding:

None

研究疾病:

术后疼痛  

Target disease:

Postsurgical pain

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

评价纳布啡、氢吗啡酮、舒芬太尼用于临床专科化镇痛的效果及不良反应;规范纳布啡、氢吗啡酮及舒芬太尼的术后PCIA镇痛合理化用药  

Objectives of Study:

To evaluate the efficacy and adverse reactions of nalbuphine, hydromorphine and Sufentanil for clinical specialized analgesia, and to standardize the rational use of nebulidine, hydromorphine and Sufentanil for postoperative PCIA analgesia

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 年龄>18岁; 2. 拟于全身麻醉妇科或胃肠道手术术后行PCIA的患者; 3. 能理解本研究过程和方法,自愿参加并签署知情同意书。

Inclusion criteria

1. Age > 18 years; 2. PCIA was performed after gynecologic or gastrointestinal surgery under general anesthesia 3. Can understand the process and method of this study, volunteer and sign the informed consent.

排除标准:

1. 采用其他镇痛方式或者采用多种镇痛方法的患者; 2. 既往有过敏史或者对麻醉药物过敏的患者; 3. 语言表达障碍或无法沟通的患者; 4. 研究者认为不适宜参加的患者;

Exclusion criteria:

1. Patients using other analgesic methods or using multiple analgesic methods; 2. Patients with a history of allergy or allergy to narcotic drugs; 3.Patients with language disorders or inability to communicate; 4. Patients considered unsuitable by the researchers;

研究实施时间:

Study execute time:

From 2025-01-01 00:00:00 To 2027-01-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-01-01 00:00:00 To 2026-01-01 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

9900

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

泸州 

Country:

China

Province:

Sichuan

City:

Luzhou

单位(医院):

广元市中心医院 

单位级别:

三级 

Institution
hospital:

Guangyuan Central Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

广元市中医医院 

单位级别:

三级 

Institution
hospital:

Guangyuan Hospital of traditional Chinese medicine

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

宜宾市第三人民医院 

单位级别:

三级 

Institution
hospital:

The third people's Hospital of Yibin

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

宣汉县人民医院 

单位级别:

三级 

Institution
hospital:

Xuanhan County People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

万源市中心医院 

单位级别:

三级 

Institution
hospital:

Wanyuan Central Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

成都大学附属医院 

单位级别:

三级 

Institution
hospital:

Affiliated Hospital of Chengdu University

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

成都市郫都区人民医院 

单位级别:

三级 

Institution
hospital:

Chengdu Pi County People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

叙永县人民医院 

单位级别:

三级 

Institution
hospital:

Xuyong County People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

大邑县人民医院 

单位级别:

三级 

Institution
hospital:

Dayi County People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

内江市第二人民医院 

单位级别:

三级 

Institution
hospital:

Neijiang Second People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

古蔺县人民医院 

单位级别:

三级 

Institution
hospital:

Gulin County People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

射洪市中医院 

单位级别:

三级 

Institution
hospital:

Shehong Hospital of traditional Chinese medicine

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

遂宁市中医院 

单位级别:

三级 

Institution
hospital:

Suining Hospital of traditional Chinese medicine

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

射洪市人民医院 

单位级别:

三级 

Institution
hospital:

Shehong People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

内江市第一人民医院 

单位级别:

三级 

Institution
hospital:

Neijiang first People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

乐山市中医医院 

单位级别:

三级 

Institution
hospital:

Leshan Hospital of traditional Chinese medicine

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

什邡市人民医院 

单位级别:

三级 

Institution
hospital:

Shifang People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

广汉市人民医院 

单位级别:

三级 

Institution
hospital:

Guanghan People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

合江县中医医院 

单位级别:

三级 

Institution
hospital:

Hejiang County Hospital of traditional Chinese medicine

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

自贡市第三人民医院 

单位级别:

三级 

Institution
hospital:

Zigong Third People's Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

自贡市第一人民医院 

单位级别:

三级 

Institution
hospital:

Zigong first People's Hospital

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

VAS疼痛评分(静息和活动)(各观察时点)

指标类型:

主要指标

Outcome:

VAS pain score (resting and activity) (at each observation point)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-12-24 08:42:53